Aliqopa Interactions
There are 340 drugs known to interact with Aliqopa (copanlisib), along with 5 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 85 are major, 253 are moderate, and 2 are minor.
- View all 340 medications that may interact with Aliqopa
- View Aliqopa alcohol/food interactions (2)
- View Aliqopa disease interactions (5)
Most frequently checked interactions
View interaction reports for Aliqopa (copanlisib) and the medicines listed below.
- acebutolol
- acetazolamide
- Advate (antihemophilic factor)
- atropine
- Comirnaty (COVID-19 mRNA (Pfizer) vaccine)
- Corlanor (ivabradine)
- dorzolamide ophthalmic
- Entresto (sacubitril / valsartan)
- Glatopa (glatiramer)
- Janssen COVID-19 Vaccine (sars-cov-2 (covid-19) ad26 vaccine, recombinant)
- Lasix (furosemide)
- Luvox CR (fluvoxamine)
- prazosin
- Precedex (dexmedetomidine)
- Rituxan (rituximab)
- Saphris (asenapine)
- Tecfidera (dimethyl fumarate)
- Timoptic-XE (timolol ophthalmic)
Aliqopa alcohol/food interactions
There are 2 alcohol/food interactions with Aliqopa (copanlisib).
Aliqopa disease interactions
There are 5 disease interactions with Aliqopa (copanlisib) which include:
Report options
More about Aliqopa (copanlisib)
- Aliqopa consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Lunsumio
Lunsumio (mosunetuzumab-axgb) is used for the treatment of relapsed or refractory follicular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.